Sentences with phrase «promising immunotherapy»

The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine developed at Roswell Park Cancer Institute.
The study consists of two phases and involves two promising immunotherapy drugs: pembrolizumab and talimogene laherparepvec (T - VEC).
Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers Drug Discovery & Development — May 14, 2015
The promising immunotherapy drug nivolumab received its first regulatory approval in July for use in inoperable melanoma in Japan, under the name Opdivo.
She translates the most promising immunotherapy strategies for breast cancer to the clinic, and is now extending these strategies to ovarian cancer.
(Drugs that block PD - 1 eliminate this immune suppression and have proven to be a promising immunotherapy cancer treatment.)
With enthusiasm for cancer immunotherapy mounting thanks to recent successes in the clinic with immune - based cancer treatments such as anti-CTLA-4 and anti-PD-1 antibodies, and the FDA approvals of sipuleucel - T prostate cancer vaccine and ipilimumab for the treatment of melanoma, and in light of the many promising immunotherapies now in clinical trials with potential for near - term FDA approval, the Cancer Research Institute launched the first annual Cancer Immunotherapy Awareness Month in June 2013 as a way to increase public awareness of the power of immunotherapy to revolutionize cancer treatment and of the need for continued public support for research to bring these treatments to more patients sooner.

Not exact matches

Dan Chen, head of Roche / Genentech's cancer immunotherapy unit, told Fortune the data were particularly promising since they could lead to Tecentriq becoming a first response treatment and give additional credence to the company's argument that immunotherapies are more effective the earlier they're given to patients.
While it has shown promise for some types of tumors and become standard of care for others, researchers are just beginning to explore how different immunotherapy technologies can be applied to brain cancer.
Other recent research into immunotherapy for glioblastoma points to promise as well as challenges.
«The event, the fourth of its kind, seeks to raise global awareness and create a forum for collaboration around the wide array of powerful and promising cell therapies, gene therapies, and immunotherapies emerging from medical institutions around the world, as well as the impact new technology will have on humanity and society,» a press release by the Cure Foundation explains (h / t Christian Post).
There are some promising studies regarding Chinese herbs and heat - killed bacteria immunotherapy, however no cure has been found yet!
A promising new field of cancer treatment is cancer immunotherapy, which helps the body's own immune system fight off cancer.
The April issue of Scientific American highlights these emerging therapies, but we have covered the growing promise of immunotherapy for quite a while.
Biden has also been talking to Los Angeles, California, oncologist and billionaire Patrick Soon - Shiong, who on 11 January announced an industry - led moonshot aimed at testing in clinical trials combinations of cancer immunotherapy drugs, one of most promising new cancer treatments in recent years.
Cancer patients are showing promising and sometimes dramatic responses to new treatments — most notably, to immunotherapy.
Today, new immunotherapy drugs have shown great promise in melanoma, but many patients fail to respond, underscoring the need to further improve the drugs» abilities.
Immunotherapy is a promising approach in the treatment of metastatic melanoma, an aggressive and deadly form of skin cancer; but for most patients, immunotherapy drugs so far have failed to live up to their promise and provide little oImmunotherapy is a promising approach in the treatment of metastatic melanoma, an aggressive and deadly form of skin cancer; but for most patients, immunotherapy drugs so far have failed to live up to their promise and provide little oimmunotherapy drugs so far have failed to live up to their promise and provide little or no benefit.
«Immunotherapy combination promising for untreated patients with advanced melanoma.»
In light of recent findings and future promises, cancer immunotherapy has even been chosen as scientific breakthrough of the year 2013 by the journal Science.
«Rationally combined immunotherapies hold great promise for cancer treatment as long as their side effects can be managed.»
«The use of the immune system through cancer immunotherapy is a very exciting field currently and promises to contribute significantly to elimination of metastatic tumors,» said Fiering.
Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer.
«Immunotherapy, gene therapy combination shows promise against glioblastoma.»
Merck CEO Kenneth Frazier explained today in The Wall Street Journal that the firm aims to rebound from recent failures and devote more resources to the company's most promising efforts, including cancer immunotherapy and diabetes research.
One form of immunotherapy called checkpoint blockade is especially promising.
Immunotherapy is a promising strategy for the treatment of Alzheimer's that uses antibodies to stimulate the immune system to remove pieces of a protein called amyloid beta which accumulates in the brain (in deposits known as plaques) and is thought to be a major factor driving Alzheimer's neurodegenerative effects.
A phase I clinical trial and a phase III clinical trial have been completed for a T - cell based immunotherapy and IL - 13 bacterial toxin fusion protein respectively, both with promising outcomes.
«New immunotherapy technique holds promise for curing food allergies.»
Focusing on gastric cancer (GC), the third leading cause of cancer death worldwide, the team's findings may also prove applicable to other major cancers with potential implications for how cancers might be better treated with immunotherapy, one of the most promising classes of anti-cancer drugs today.
Together, these and other findings strongly suggest that immunotherapies that can induce or enhance optimal immunologic conditions within ovarian cancers may hold great promise for extending the lives of ovarian cancer patients.
In his acceptance speech, Parker praised scientists and clinicians for work that went unrecognized until recently when cancer immunotherapy started showing very promising treatment results.
One of the most promising areas of cancer research and treatment is known as immunotherapy, in which a patient's own immune system is enlisted in the fight against cancer.
«Motolimod holds considerable promise as a cancer drug, particularly as a component of combination immunotherapies.
«The Cancer Research Institute plays a very important role to support the work of scientists who have original ideas of cancer immunotherapy, which are promising, but not yet proven enough for obtaining financial support from commercial groups.
-- Checkmate Pharmaceuticals of Cambridge, MA, has nudged its way into the combination immunotherapy game with promising early data presented Monday.
The symposium features presentations by Philippa Marrack and John Kappler talking on the T cell repertoire; William Paul on interleukin 4 as a prototypic immunoregulatory cytokine; Timothy Springer on lymphocyte trafficking; Pamela Bjorkman on structural studies of MHC and MHC - related proteins, and Jack Strominger on peptide presentation by class I and II MHC proteins; Thierry Boon on genes coding for tumor rejection antigens, including the first tumor antigen, MAGE - 1; and Philip Greenberg on the modification of T cells for adoptive therapy by retroviral - mediated gene insertion Since then, the symposia series has attracted leading immunologists in the cancer vaccine and antibody fields, providing them with a comprehensive view of the promises and challenges in the development of cancer immunotherapies.
Immunotherapy as a potentially promising treatment for ovarian cancer is based on several lines of evidence.
June 2, 2016 Novel immunotherapy approach shows promise in blood cancers A protein known as STING plays a crucial role in the immune system's ability to «sense» cancer by recognizing and responding to DNA from tumor cells.
Immunotherapies are a promising new strategy to fight multiple myeloma.
«These are very promising findings and, as the first study to demonstrate protection from Zika in the pregnancy setting, are an important development in our efforts to combat Zika virus,» said Michael Diamond, M.D., Ph.D., Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology, and Associate Director, Center for Human Immunology and Immunotherapy Program at Washington University School of Medicine, and a lead author on the Cell paper.
Research into immunotherapy, which cancer experts are calling the most promising approach in decades, got a boost Tuesday when Michael Bloomberg and other philanthropists announced $ 125 million in donations to Johns Hopkins University for a new institute focused solely on the therapy and accelerated breakthroughs for patients.
We've come to the tipping point now where there is acceptance that immunotherapy can provide a long - lasting effect and has a lot of promise.
A live attenuated bioengineered bacteria - vectored vaccine immunotherapy is well tolerated and appears to be associated with promising overall survival among women with persistent / recurrent metastatic cervical cancer.
Hence, despite of all the negative reaction to immunotherapy because of questioable bad results, it seems that so far is the only promising approach..
Hence, despite of all the negative reaction to immunotherapy because of questionable bad results, it seems that so far is the only promising approach..
Much of the research to be presented is focused on immunotherapy, which is seen as the most promising advance in cancer treatment in decades.
Patients with metastatic melanoma, or melanoma that has spread to other parts of the body, often have a poor prognosis, and while some forms of immunotherapy — treatments that boost the body's immune system to fight disease — are promising, response rates are less than 35 percent.
AST - VAC1 (antigen - presenting autologous dendritic cells) is an autologous cancer immunotherapy with promising efficacy and safety data from a Phase 2 study in Acute Myeloid Leukemia (AML).
Lentiviral vectors are promising agents for cancer immunotherapy, but this research is still in the pre - clinical / early clinical stages.
a b c d e f g h i j k l m n o p q r s t u v w x y z